SCHEMBL26790700

SCHEMBL26790700

Cc1nc2c(F)c(C#C[Si](C)(C)C)c(Cl)cc2n1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26790705 0.82 KDM4E (0.31) —
SCHEMBL26790716 0.77 SMC2 (0.32) —
SCHEMBL24463640 0.74 KDM4E (0.33) —
SCHEMBL30391150 0.74 KDM4E (0.33) —
SCHEMBL28995731 0.73 CYP1A2 (0.33) —
SCHEMBL30390530 0.73 CYP1A2 (0.33) —
SCHEMBL26790783 0.71 NPC1 (0.31) —
SCHEMBL26790682 0.70 KDM4E (0.44) —
SCHEMBL24463148 0.70 KDM4E (0.33) —
SCHEMBL24463421 0.69 LMNA (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374015-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KINNATE BIOPHARMA INC. 2023-11-23 — — US disclosed
US-20230374015-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KINNATE BIOPHARMA INC. 2023-11-23 — — US disclosed
Send feedback